Greenwich LifeSciences GLSI
NASDAQ GLSI
$18.06 -0.32 (-1.74%)
As of: Sep 30, 2026 · 3:59 PM EDT

Greenwich LifeSciences (GLSI) Total Non-Current Liabilities (2024 - 2026)

Updated

Greenwich LifeSciences' Total Non-Current Liabilities was $4.56 million in Q1 2026, up 103.3% from $2.24 million a year earlier but down 11.4% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Greenwich LifeSciences came in at $5.15 million, up 78.9% from FY2024.

  • In earlier years, Total Non-Current Liabilities was $2.88 million in FY2024.
  • Quarterly Total Non-Current Liabilities has moved between $1.38 million (Q2 2025) and $5.15 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Greenwich LifeSciences 269.56 Mn 269.56 Mn - 4.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.56 Mn
Dec 31, 2025 5.15 Mn
Jun 30, 2025 1.38 Mn
Mar 31, 2025 2.24 Mn
Dec 31, 2024 2.88 Mn
API Access

Greenwich LifeSciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GLSI&period=max&api_key=YOUR_API_KEY